ID   H22-F25/L
AC   CVCL_E7BW
RX   DOI=10.1007/BF02954998;
RX   PubMed=1889333;
CC   Doubling time: 20.7 hours (DOI=10.1007/BF02954998; PubMed=1889333).
CC   Karyotypic information: 43,XY,-2,+M1,+M2,+M3,+M4 (DOI=10.1007/BF02954998; PubMed=1889333).
CC   Transformant: ChEBI; CHEBI_82285; Ortho-aminoazotoluene (OAAT).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C3HA.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_H613 ! H22
OI   CVCL_3854 ! MH-22a
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
RX   DOI=10.1007/BF02954998;
RA   Ling M.-Y., Zheng H.-Z., Long X., Liu X.-F., Gu S.-Z.;
RT   "Establishment of a murine ascites hepatoma cell line H22-F25/L and
RT   its biological characteristics.";
RL   Chin. J. Cancer Res. 4:32-36(1992).
//
RX   PubMed=1889333;
RA   Ling M.-Y., Zheng H.-Z., Long X., Liu X.-F., Gu S.-Z.;
RT   "Establishment of a murine ascites hepatoma cell line H22-F25/L and
RT   its biological characteristics.";
RL   Zhonghua Zhong Liu Za Zhi 13:13-15(1991).
//